{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T15:57:45Z","timestamp":1760975865485},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,9,4]],"date-time":"2012-09-04T00:00:00Z","timestamp":1346716800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1007\/s00228-012-1384-5","type":"journal-article","created":{"date-parts":[[2012,9,3]],"date-time":"2012-09-03T07:15:53Z","timestamp":1346656553000},"page":"721-724","source":"Crossref","is-referenced-by-count":11,"title":["A probable clinically significant interaction between warfarin and cloxacillin: three case reports"],"prefix":"10.1007","volume":"69","author":[{"given":"Hossein","family":"Khalili","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naemeh","family":"Nikvarz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farhad","family":"Najmeddin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simin","family":"Dashti-Khavidaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,9,4]]},"reference":[{"key":"1384_CR1","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1001\/archinte.165.10.1095","volume":"165","author":"AM Holbrook","year":"2005","unstructured":"Holbrook AM, Pereira JA, Labiris R, MacDonald H, Duketis JD, Crowther M et al (2005) Systematic overview of warfarin and its drug and food interactions. Arch Intern Med 165:1095\u20131106","journal-title":"Arch Intern Med"},{"issue":"6 suppl","key":"1384_CR2","doi-asserted-by":"crossref","first-page":"160S","DOI":"10.1378\/chest.08-0670","volume":"133","author":"J Ansell","year":"2008","unstructured":"Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther M, Palareti G (2008) Pharmacology and management of the vitamin K antagonists. American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest 133[6 Suppl]:160S\u2013198S","journal-title":"Chest"},{"key":"1384_CR3","doi-asserted-by":"crossref","first-page":"527","DOI":"10.7326\/0003-4819-100-4-527","volume":"100","author":"GD Qureshi","year":"1984","unstructured":"Qureshi GD, Reinders TP, Somori GJ, Evans HJ (1984) Warfarin resistance with nafcillin therapy. Ann Intern Med 100:527\u2013529","journal-title":"Ann Intern Med"},{"key":"1384_CR4","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1592\/phco.27.10.1467","volume":"27","author":"KY Kim","year":"2007","unstructured":"Kim KY, Frey RJ, Epplen K, Foruhari F (2007) Interaction between warfarin and nafcillin: case report and review of the literature. Pharmacotherapy 27:1467\u20131470","journal-title":"Pharmacotherapy"},{"issue":"6","key":"1384_CR5","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1177\/106002809102500605","volume":"25","author":"VA Shovick","year":"1991","unstructured":"Shovick VA, Rihn TL (1991) Decreased hypoprothrombinemic response to warfarin secondary to the warfarin\u2013nafcillin interaction. DICP 25(6):598\u2013600","journal-title":"DICP"},{"key":"1384_CR6","first-page":"182","volume":"39","author":"AT Taylor","year":"1994","unstructured":"Taylor AT, Pritchard DC, Goldstein AO, Fletcher JL Jr (1994) Continuation of warfarin-nafcillin interaction during dicloxacillin therapy. J Fam Pract 39:182\u2013185","journal-title":"J Fam Pract"},{"key":"1384_CR7","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1345\/aph.1D484","volume":"38","author":"CS Lacey","year":"2004","unstructured":"Lacey CS (2004) Interaction of dicloxacillin with warfarin. Ann Pharmacother 38:898","journal-title":"Ann Pharmacother"},{"key":"1384_CR8","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1080\/14017439950141443","volume":"33","author":"S Halvorsen","year":"1999","unstructured":"Halvorsen S, Husebye T, Arnesen H (1999) Prosthetic heart valve thrombosis during dicloxacillin therapy. Scand Cardiovasc J 33:366\u2013368","journal-title":"Scand Cardiovasc J"},{"key":"1384_CR9","first-page":"804","volume":"6","author":"PM Krstenansky","year":"1987","unstructured":"Krstenansky PM, Jones WN, Garewal HS (1987) Effect of dicloxacillin sodium on the hypoprothrombinemic response to warfarin sodium. Clin Pharm 6:804\u2013806","journal-title":"Clin Pharm"},{"key":"1384_CR10","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1177\/106002809603001208","volume":"30","author":"AT Mailloux","year":"1996","unstructured":"Mailloux AT, Gidal BE, Sorkness CA (1996) Potential interaction between warfarin and dicloxacillin. Ann Pharmacother 30:1402\u20131407","journal-title":"Ann Pharmacother"},{"key":"1384_CR11","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00228-010-0802-9","volume":"66","author":"A Merwick","year":"2010","unstructured":"Merwick A, Hannon N, Kelly PJ, O\u2019Rourke K (2010) Warfarin\u2013flucloxacillin interaction presenting as cardioembolic ischemic stroke. Eur J Clin Pharmacol 66:643\u2013644","journal-title":"Eur J Clin Pharmacol"},{"key":"1384_CR12","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1345\/aph.1L676","volume":"43","author":"A Garg","year":"2009","unstructured":"Garg A, Mohammed M (2009) Decreased INR response secondary to warfarin\u2013flucloxacillin interaction. Ann Pharmacother 43:1374\u20131375","journal-title":"Ann Pharmacother"},{"key":"1384_CR13","doi-asserted-by":"crossref","first-page":"613","DOI":"10.5694\/j.1326-5377.2011.tb03122.x","volume":"194","author":"PY Choi","year":"2011","unstructured":"Choi PY, Phillips KL, Rae I (2011) High-dose intravenous flucloxacillin may affect warfarin therapy. Med J Aust 194:613","journal-title":"Med J Aust"},{"key":"1384_CR14","first-page":"56","volume":"4","author":"OM Ibrahim","year":"1996","unstructured":"Ibrahim OM, Allam A (1996) Warfarin resistance in a patient with prosthetic valve endocarditis treated with cloxacillin. Saudi Pharm J 4:56\u201359","journal-title":"Saudi Pharm J"},{"key":"1384_CR15","doi-asserted-by":"crossref","first-page":"431","DOI":"10.5414\/CP201700","volume":"50","author":"S Marusic","year":"2012","unstructured":"Marusic S, Gojo-Tomic N, Bacic-Vrca V, Franic M (2012) Enhanced anticoagulant effect of warfarin in a patient treated with cloxacillin. Int J Clin Pharmacol Ther 50:431\u2013433","journal-title":"Int J Clin Pharmacol Ther"},{"key":"1384_CR16","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1365-2125.1994.tb04251.x","volume":"37","author":"PE Rolan","year":"1994","unstructured":"Rolan PE (1994) Plasma protein binding displacement interactions-why are they still regarded as clinically important? Br J Clin Pharmacol 37:125\u2013128","journal-title":"Br J Clin Pharmacol"},{"key":"1384_CR17","unstructured":"Baxter K (ed) (2010) Stockley's drug interactions: a source book of interactions, their mechanisms, clinical importance and management, 9th edn. Pharmaceutical Press, London, p 426"},{"key":"1384_CR18","doi-asserted-by":"crossref","unstructured":"Piscitelli SC, Rodvold KA, Pai MP (eds) (2011) Drug interactions in infectious diseases, 3rd edn. Humana Press, New York","DOI":"10.1007\/978-1-61779-213-7"},{"key":"1384_CR19","doi-asserted-by":"crossref","first-page":"450","DOI":"10.2165\/00003088-199325060-00005","volume":"25","author":"JG Gillum","year":"1993","unstructured":"Gillum JG, Israel DS, Polk RE (1993) Pharmacokinetic drug interactions with antimicrobial agents. Clin Pharmacokinet 25:450\u2013482","journal-title":"Clin Pharmacokinet"},{"key":"1384_CR20","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1345\/aph.1H423","volume":"41","author":"JR Horn","year":"2007","unstructured":"Horn JR, Hansten PD, Chan LN (2007) Proposal for a new tool to evaluate drug interaction cases. Ann Pharmacother 41:674\u2013680","journal-title":"Ann Pharmacother"},{"key":"1384_CR21","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3821\/1913-701X-144.1.21","volume":"144","author":"TJ Bungard","year":"2011","unstructured":"Bungard TJ, Yakiwchuk E, Foisy M, Brocklebank C (2011) Drug interactions involving warfarin: practice tool and practical management tips. Can Pharm J 144:21\u201325","journal-title":"Can Pharm J"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-012-1384-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-012-1384-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-012-1384-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T03:55:51Z","timestamp":1594612551000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-012-1384-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,4]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["1384"],"URL":"https:\/\/doi.org\/10.1007\/s00228-012-1384-5","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,4]]}}}